Misha Denissenko

Misha Denissenko is a seasoned professional in biotechnology and pharmaceutical project management, currently serving as Director of Program Management at Hologic, Inc. since 2018, where responsibilities include governance enforcement and project portfolio management across multiple sites. Co-founder and Partner at Gen10 Bioscience since 2014, Misha has successfully developed business strategies and managed product development projects. As COO and Board Member of The Releef Initiative, Misha focuses on creating affordable healthcare solutions for underserved populations. Previous roles include Director of Project & Portfolio Management at Prometheus Laboratories, Associate Director at Thermo Fisher Scientific, and Group Leader at both Sequenom and BD, with a strong foundational education encompassing a Post-doctoral in Oncology and Cancer Biology and a PhD in Biological Sciences.